You only help the company and others by adding further cash in a capital raise. Buying shares from someone else is not altruistic.
Nice feelings all round but the gushy tone of the Prima postings takes no account of the multiple set backs in biotech.
Virax had great promise with its immunotherapy but failed. That has no bearing on Prima but some cool appraisal could help.
why we love prima biomed , page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.055(18.6%) |
Mkt cap ! $504.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $5.701M | 15.98M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 404501 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 314966 | 6 |
View Market Depth
| Last trade - 15.18pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |